Implications of an early diagnosis of Alzheimer’s disease

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

  1. Alzheimer’s Disease International. Importance of early diagnosis. Available at: Accessed 26 June 2021.
  2. Jack CR, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement 2018;7:257–62.
  3. Palmqvist S, et al. Performance of fully automated plasma assays as screening tests for Alzheimer disease–related β-Amyloid status. J Alzheimers Dis 2018;62:1857–63.
  4. Karikari TK, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol 2020;19:422–33.
  5. Mattsson-Carlgren N, et al. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease. Brain 2020;143:3234–41.
  6. Dubois B, et al. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. Lancet Neurol 2021;20:484–96.
Du lämnar Progress in Mind Sverige
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
Den här informationen är endast avsedd för hälso- och sjukvårdspersonal
Register for access to Progress in Mind in your country